Related Experiment Video
Updated: Sep 27, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood
Dae-Hee Kim1, In-Jeong Cho2, Woohyeun Kim3
1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Insights
Elevated diastolic blood pressure (DBP) according to JNC7 guidelines increases cardiovascular event risk, even when systolic blood pressure (SBP) is controlled. The 2017 ACC/AHA guidelines showed a link only to stroke risk.
Area of Science:
- Cardiology
- Hypertension Research
- Public Health
Background:
- Hypertension management guidelines differ in their definitions of elevated blood pressure.
- Assessing the impact of different diastolic blood pressure (DBP) thresholds on cardiovascular outcomes is crucial for optimizing treatment strategies.
- Understanding the association between on-treatment blood pressure levels and cardiovascular events is vital for patient care.
Purpose of the Study:
- To investigate the association between cardiovascular events and two distinct levels of elevated on-treatment diastolic blood pressure (DBP).
- To compare the risk of major cardiovascular events when systolic blood pressure (SBP) targets are met but DBP remains elevated, using different guideline definitions.
- To provide evidence for setting appropriate DBP targets in patients who have achieved their SBP targets.
Main Methods:
- A nationwide, population-based cohort study involving 237,592 treated hypertensive patients.
- Primary endpoint: composite of cardiovascular death, myocardial infarction, and stroke.
- Elevated DBP was defined using the Seventh Report of the Joint National Committee (JNC7) and the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines.
Main Results:
- Elevated on-treatment DBP by JNC7 definition was linked to increased risk of the primary endpoint (aHR, 1.14; 95% CI, 1.05-1.24).
- JNC7-defined elevated DBP was associated with higher risks of cardiovascular mortality (aHR, 1.42) and stroke (aHR, 1.19).
- 2017 ACC/AHA-defined elevated DBP was associated only with an increased risk of stroke (aHR, 1.10).
Conclusions:
- Elevated on-treatment DBP, particularly by the JNC7 definition, poses a significant risk for major cardiovascular events.
- The 2017 ACC/AHA definition of elevated DBP was primarily associated with an increased risk of stroke.
- Findings support the importance of monitoring and managing DBP even when SBP targets are achieved, with implications for guideline refinement.
Background And Objectives:
This study aimed to investigate the association between cardiovascular events and 2 different levels of elevated on-treatment diastolic blood pressures (DBP) in the presence of achieved systolic blood pressure targets (SBP).
Methods:
A nation-wide population-based cohort study comprised 237,592 patients with hypertension treated. The primary endpoint was a composite of cardiovascular death, myocardial infarction, and stroke. Elevated DBP was defined according to the Seventh Report of Joint National Committee (JNC7; SBP <140 mmHg, DBP ≥90 mmHg) or to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) definitions (SBP <130 mmHg, DBP ≥80 mmHg).
Results:
During a median follow-up of 9 years, elevated on-treatment DBP by the JNC7 definition was associated with an increased risk of the occurrence of primary endpoint compared with achieved both SBP and DBP (adjusted hazard ratio [aHR], 1.14; 95% confidence interval [CI], 1.05-1.24) but not in those by the 2017 ACC/AHA definition. Elevated on-treatment DBP by the JNC7 definition was associated with a higher risk of cardiovascular mortality (aHR, 1.42; 95% CI, 1.18-1.70) and stroke (aHR, 1.19; 95% CI, 1.08-1.30). Elevated on-treatment DBP by the 2017 ACC/AHA definition was only associated with stroke (aHR, 1.10; 95% CI, 1.04-1.16). Similar results were seen in the propensity-score-matched cohort.
Conclusion:
Elevated on-treatment DBP by the JNC7 definition was associated a high risk of major cardiovascular events, while elevated DBP by the 2017 ACC/AHA definition was only associated with a higher risk of stroke. The result of study can provide evidence of DBP targets in subjects who achieved SBP targets.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Errors occurring during blood pressure monitoring
Several factors...
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension V: Nursing Management

